Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #404

    7 gange så mange MM. Amy 50-80 år http://amyloidosis.org/facts/al/

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #405

      Nu vi er ved isa. Ud over at de altså allerede har en sc-version i klinikken, så kører de ufortrødent på med isa+atezo i solide. https://www.clinicaltrials.gov/ct2/show/NCT03637764?term=isatuximab+atezolizumab&rank=1

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #406

        Link Preview Image
        Analysehus: MSD's Keytruda bliver verdens bedst sælgende lægemiddel i 2025

        En fremskrivning fra analysehuset Globaldata viser, at MSD's kræftmiddel Keytruda vil være verdens bedst sælgende lægemiddel om fem år, mens den nuværende topsællert, Abbvies inflammationsmidddel Humira, vil falde til nummer seks.

        favicon

        (medwatch.dk)

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #407

          Vi må håbe at Darzalex snart indfinder sig på listen - tænker at nogen analytikere forventer at den kan kæmpe med om de laveste pladser i 2025

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #408

            Godt nok skuffende hvis det ender med at isatuximab får et gennembrud i solide før daratumumab

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #409

              Jo lidt underligt, at JNJ ikke kommer efter solide. Men er der ikke noget med de selv har en PD-1 under udvikling og måske vil afvente den.

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #410

                Jeg ser stadig ikke de kan hente dara i MM. De har på ingen måde bevist de er bedre, hvorfor de får meget svært ved at fortrænge dara.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #411

                  Der kan være lidt her: However, one particular difference is that unlike Darzalex, it is not associated with complement activation, meaning it can be more readily given to patients with asthma or chronic obstructive pulmonary disease.
                  “It’s not a trivial population,” said Dr. Paul Richardson. https://medcitynews.com/2019/06/sanofis-isatuximab-shines-in-myeloma-at-asco-but-where-will-it-fit-into-treatment/?rf=1

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #412

                    Der kører da forsøg med dara i solide ? https://www.clinicaltrials.gov/ct2/show/NCT03098550?term=daratumumab+solid&rank=2

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #413

                      Jo da men det er et BMS forsøg. Så ikke megen aktivitet fra JNJs side.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #414

                        Cetrelimab hedder JNJ PD1 https://clinicaltrials.gov/ct2/show/NCT02908906

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #415

                          Solsen tror absolut heller ikke isatuximab vil erstatte daratumumab, men der kommer trods alt en del Mm drugs på makredet - og hvis enkelte af dem nupper en halv til hel milliard dollars af omsætningen, så kan det være peaksale måske ender 1-3 milliarder dollars lavere i MM

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #416

                            isatuximab kan eksempelvis begynde at spille på pris, men der er stadig lang vej til de er repræsenteret så bredt som daratumumab er.

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #417

                              de 1-3 milliarder USD kan amyloidosis så passende kompensere for...

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #418

                                My understanding from the last JNJ R&D day was that they would wait with solid until the SC approval

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #419

                                  Lebowitz said that in that earlier lung trial the concern was that steroids are taking away from the immune response. He adds: we have developped (and into the clinic) a steroid sparing regimen where we can get the streroids off -and we needed the SC to do that

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #420

                                    And once we have those pieces in place I think we retest that hypothesis on immunomodulatory properties of darzalex

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #421

                                      https://edge.media-server.com/mmc/p/jjsewqjm 4:33:30

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #422

                                        Jan said earlier that they also needed approval of sc dara in MM first - they didnt want to jepardizy that with deaths in solids I guess

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #423

                                          i remember you writing that exact sentence before 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger